Moreover, due to higher insulin/insulin-like growth factor signaling, men with prostate cancer harboring the TMPRSS2-ERG gene fusion are more susceptible to obesity and hence have poorer prognosis than those not harboring the gene fusion [175]. The gene discussed is ERG; the disease is Familial prostate cancer.